Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-035727
Filing Date
2022-11-14
Accepted
2022-11-14 17:45:53
Documents
1
Period of Report
2022-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10771
  Complete submission text file 0000899243-22-035727.txt   12266
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address INTERNATIONAL FLAVORS & FRAGRANCES INC. 521 W. 57TH STREET NEW YORK NY 10019
Business Address
Epstein David R (Reporting) CIK: 0001445826 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 221388231